Lucile Blaise - 01 Jul 2022 Form 3 Insider Report for RESMED INC (RMD)

Signature
Lucile Blaise, President, Sleep & Respiratory Care
Issuer symbol
RMD
Transactions as of
01 Jul 2022
Net transactions value
$0
Form type
3
Filing time
15 Jul 2022, 18:23:40 UTC
Next filing
18 Nov 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RMD ResMed Common Stock 6,915 01 Jul 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects beneficially owned shares as of July 1, 2022 when Ms. Blaise was appointed as an executive officer.